Navigation Links
Generic Drugs: World Market Outlook 2011-2021
Date:11/2/2011

ric Drugs (Generics)

2.1.1 Authorised, Branded and True Generics

2.2 The 'Evergreening' of Pharmaceuticals

2.3 Restraints Facing the World Pharmaceutical Market

2.4 Branded Pharmaceuticals: End of a Business Model?

2.5 US Regulations

2.5.1 Obtaining FDA Approval: NDAs and ANDAs

2.5.2 The Hatch-Waxman Act Title 1: Promotion of Generic Drugs

2.5.3 The Hatch-Waxman Act Title 2: Incentives for the Branded Industry

2.5.4 Consequences of the Hatch-Waxman Act

2.5.5 Me First: Timing as a Crucial Factor

2.6 European Regulations

2.6.1 Generics' Entry into the European Markets

2.6.2 Further Protection of Branded Products in the European Market

2.6.3 Variations among European Countries

2.6.4 Moving Towards Standardisation

2.6.5 The 8+2+1 Rule

2.7 Japanese Regulations

2.8 Compulsory Licensing

2.9 Generic Drugs: Overview

3. The World Generic Drugs Market, 2011-2021

3.1 The World Generic Pharmaceuticals Market in 2010 

3.2 Generic Products to Benefit from Patent Expiries

3.2.1 Sales Forecast for the World Generic Drugs Market, 2011-2015

3.2.2 Sales Forecast for the World Generic Drugs Market, 2016-2021

3.3 Global Market Breakdown, 2011-2021

4. Leading Companies in the World Generics Market

4.1 Teva Pharmaceutical Industries - Prospects from 2011

4.1.1 ANDAs and Approvals

4.1.2 M&A Activity

4.2 Sandoz - Prospects from 2011

4.3 Mylan - Prospects from 2011

4.3.1 Mylan's Acquisition of Bioniche Pharma Holdings

4.4 Apotex - Prospects from 2011

4.5 Hospira - Prospects from 2011

4.5.1 Acquisition of Orchid's Generic Injectable Pharmaceutical Business

4.5.2 Hospira's Acquisition of Javelin Pharma

4.6 Watson - Prospects from 2011

4.6.1 ANDAs and Approvals

4.6.2 M&A Activity

4.6.3 Eden Becomes
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Multi-therapy Drugs: Opportunities for Generics & Biosimilars
2. Perrigo Announces Launch of Generic Version of Elestat®
3. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
4. Mylan Receives Approval for Generic Version of MS Contin® Tablets
5. FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers Access to Lower-Cost Generic Drugs
6. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
7. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
8. Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis®
9. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
10. Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
11. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... N.J. , Aug. 1, 2014  PTC Therapeutics, ... on July 31, 2014 it approved non-statutory stock options ... common stock to seven new employees. The awards were ... a component of our new hires, employment compensation. ... Committee on July 31, 2014 and are being made ...
(Date:8/1/2014)... , Aug. 1, 2014  With monumental health reform ... speak a second language. Clinical efficacy is no longer ... under the ACA like PCORI are directing roughly $1 ... of new entities and environments, the federal healthcare ecosystem ... new language of outcomes and managed markets to the ...
(Date:8/1/2014)... YORK , Aug. 1, 2014  Valeant Pharmaceuticals ... L.P. today responded to the filing of a federal ... in California.  The complaint makes baseless claims about Valeant ... Allergan,s true purpose in bringing the litigation ... call a special meeting.  That purpose is made clear ...
Breaking Medicine Technology:PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6
... 23, 2012  Doctors and other healthcare professionals have grown increasingly ... is taking with regard to Fosamax - a widely used ... fractures. The FDA has so far resisted ... prolonged use. Such labels are necessary in light of the ...
... BEIJING, Feb. 23, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... an emerging leader in the development, assembly, marketing and ... announced that for the year ended December 31, 2011, ... led by the Ministry of Science and Technology of ...
Cached Medicine Technology:Victims of Abnormal Bone Fractures Await Action as FDA Lingers on Edge of Tightening Fosamax Regulations 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 3
(Date:8/1/2014)... Cannabis use among young people has spiked, with ... used marijuana at least once and 17 percent admitting to ... Drugs, Say ‘Yes to Life,’ volunteers from the Church of ... with factual information about drugs, to help reverse this alarming ... to Drugs, Say ‘Yes’ to Life,” volunteers have distributed 40,000 ...
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation ... therapy caused strokes, heart attacks, and other injuries in ... F. Kennelly as the transferee judge and ordered what ... federal court. , As one of his first organizing ... of attorneys who will move the litigation forward on ...
(Date:8/1/2014)... San Diego School of Medicine report that dietary capsaicin ... chronic activation of a receptor on cells lining the ... the risk of colorectal tumors. , The findings are ... The Journal of Clinical Investigation . , The receptor ... sensory neurons, where it acts as a sentinel for ...
(Date:8/1/2014)... at Washington University School of Medicine in St. Louis ... males and frequently are more harmful than similar tumors ... brain tumors, are diagnosed twice as often in males, ... not survive as long. , The researchers found that ... risk, is significantly less active in male brain cells ...
(Date:8/1/2014)... a central role in regulating appetite and whole-body metabolism. ... brain,s control of food intake and body weight, but ... been unclear. A new study in the ... activity in a type of neuron known as pro-opiomelanocortin ... high-fat diet. Sabrina Diano and colleagues at Yale ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:Study reveals one reason brain tumors are more common in men 2
... the University of Warwick and the Indian Institute of Technology ... to transport iron safely through our blood stream can, in ... fibrils banded by lines of iron rust. This process could ... the brain to cause some forms of Parkinsons & Alzheimers ...
... 8 Antidepressant medications,which increase serotonin neurotransmitter ... can increase depression, impulsivity and,suicide risk in ... physicians prescribe serotonin enhancement medications to dopamine,deficient ... and,suicidal," said Dr. Rick Sponaugle, Medical Director ...
... tool powered by SNAPforSeniors(R) helps members quickly,locate safe housing, ... rash of tornadoes in more than 20 years destroyed ... Tennessee Tuesday night., Emergency warnings gave most residents ... housing, natural disasters bring extra fears. Lack,of mobility, limited ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a ... United States, announced today that,the time of its fourth ... to February 13, 2008 at 4:30 p.m. (ET). The ... on February 13, 2008., Conference Call & Web ...
... (Nasdaq: MLAB ) today announced that its ... dividend of ten cents per share of common,stock, ... record at the close of,business on February 25, ... markets,electronic instruments for industrial, pharmaceutical and medical,applications., ...
... poorly one year later, study found , , FRIDAY, Feb. 8 ... sufficient reason for most people to change to a heart-healthy ... quality is poor after a coronary heart disease event," said ... at the University of Massachusetts Medical School, in Worcester. , ...
Cached Medicine News:Health News:Iron banded worms drying out of blood could be linked to Parkinson's and Alzheimer's 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 3Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 2Health News:Tennessee Tornadoes Spur Senior Move Managers to Aid Elderly in Crisis 3Health News:NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call 2Health News:Heart Attack Seldom Leads to Healthier Diet 2Health News:Heart Attack Seldom Leads to Healthier Diet 3
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
View Mex-3 is designed for out-patient surgery, hospital rounds and house calls....
Medicine Products: